Systems, devices and methods for performing medical procedures in the intestine

1. A method for treating polycystic ovarian syndrome, said method comprising:

selecting a patient diagnosed as having polycystic ovarian syndrome;

treating a target mucosal tissue of the patient's small intestine to modify at least one of nutrient absorption by the target mucosal tissue, hormonal signaling from the target mucosal tissue, and secretions of the target tissue, wherein the treatment is configured to treat polycystic ovarian syndrome.

2. The method according to claim 1 , wherein the method is further configured to treat insulin resistance.

3. The method according to claim 1 , wherein the method is further configured to treat a disease or disorder selected from the group consisting of: Type 2 diabetes; Type 1 diabetes; “Double diabetes”; gestational diabetes; hyperglycemia; pre-diabetes; impaired glucose tolerance; insulin resistance; and combinations thereof.

4. The method according to claim 1 , wherein treatment is performed with a system comprising:

a catheter for insertion into the patient's small intestine, the catheter comprising:

an elongate shaft comprising a distal portion; and

a functional assembly positioned on the shaft distal portion and comprising at least one treatment element; and

a console operably attached to the functional assembly, and wherein the console comprises one or more variable console parameters used to control the functional assembly; and

wherein treatment comprises:

introducing the catheter into the patient; and

treating the target mucosal tissue of the patient's small intestine with the at least one treatment element.

5. The method according to claim 4 , wherein the system further comprises at least one sensor constructed and arranged to produce a sensor signal, and wherein the method further comprises adjusting at least one variable console parameter based on the sensor signal.

6. The method according to claim 5 , wherein the console is configured to perform closed-loop energy delivery to the functional assembly based on the sensor signal.

7. The method according to claim 4 , wherein the treating target mucosal tissue comprises a series of tissue ablation steps, each comprising ablation of an axial length of intestinal tissue, wherein each ablation step is preceded by a tissue expansion step.

8. The method according to claim 7 , further comprising preventing axial motion of the functional assembly between the tissue expansion and the tissue ablation steps.

9. The method according to claim 7 , further comprising applying vacuum to tissue during each tissue expansion step.

10. The method according to claim 4 , further comprising maintaining the functional assembly at or below a target diameter.

11. The method according to claim 4 , further comprising maintaining the functional assembly at or below a target volume.

12. The method according to claim 4 , wherein the functional assembly includes a tissue contacting portion comprising a surface area between 500 mm2 and 3500 mm2.

13. The method according to claim 4 , where the functional assembly comprises an expanded diameter between 19 mm and 28 mm.

14. The method according to claim 4 , wherein the catheter further comprises a fluid removal port configured to remove fluid from a segment of the patient's small intestine.

15. The method according to claim 1 , wherein the treating target mucosal tissue comprises treating mucosal tissue within 15 cm of the ampulla of Vater.

16. The method according to claim 1 , wherein the method comprises avoiding treating tissue between a first location proximate the ampulla of Vater and a second location 0.5 cm distal to the ampulla of Vater.

17. The method according to claim 1 , wherein at least 6 cm of length of duodenum are treated.

18. The method according to claim 17 , wherein at least 9 cm of length of duodenum are treated.

19. The method according to claim 1 , wherein the treating target mucosal tissue comprises treating at least a first axial segment and a second axial segment of the patient's small intestine.

20. The method according to claim 19 , wherein the treating target mucosal tissue comprises treating between two and six axial segments of the patient's small intestine to treat at least 6 cm of axial length of intestine.

21. The method according to claim 1 , wherein the treating target mucosal tissue comprises treating an amount of tissue that is based on the severity of the patient's PCOS.

22. The method according to claim 1 , further comprising identifying non-target tissue, wherein the non-target tissue is identified by marking tissue selected from the group consisting of: ampulla of Vater; tissue proximate the ampulla of Vater; pylorus; tissue proximate the pylorus; and combinations thereof.

23. The method according to claim 1 , wherein the treating target mucosal tissue comprises a series of tissue ablation steps, each ablation step comprising ablation of an axial length of intestinal tissue, wherein each ablation step is followed by a tissue neutralizing step.

24. The method according to claim 23 , wherein each ablation step comprises a heat ablation of tissue and each neutralizing step comprises a cooling of tissue.

25. The method according to claim 23 , further comprising performing a separate tissue neutralizing step prior to each ablation step.

26. The method according to claim 25 , wherein each ablation step comprises a heat ablation of tissue and each separate neutralizing step comprises a cooling of tissue.

27. The method according to claim 1 , further comprising delivering an anti-peristaltic agent.

28. The method according to claim 1 , further comprising modifying the pressure of a segment of patient's small intestine that is proximate the target mucosal tissue being treated.